ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Assess whether Risk Parity or index funds better suit your retirement plan by examining diversification, cost, and potential risk/return trade-offs.
27,926 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Lenders are adopting a risk-aware approach to growth in 2026, blending disciplined risk controls with cross-functiona...
Rising debt costs and energy shocks are echoing through crypto markets. Analysts warn the signs point to tripwires th...
A hedge fund trend today centers on a lean, two-name portfolio. INDUS Capital Partners boosted its bet on H World Gro...
As Berkshire Hathaway enters a new chapter, investors wonder if berkshire's just break from Buffett's time-tested pla...
A new crackdown targets the cartel’s use of digital money to move profits. Learn how treasury sanctions sinaloa carte...
Nvidia investors should watch TSMC's latest results closely. When the world’s largest chipmaker signals stronger dema...
Energy stocks surged this month on higher oil prices driven by regional tensions, but market observers say valuations...
Global brain health costs total $5 trillion annually, with forecasts for $16 trillion by 2030. The crisis is reshapin...
Analysts issued a fresh round of high-conviction calls Wednesday, spotlighting Arm Holdings, BorgWarner, GM, Mondelez...
Chip stocks are rising on AI infrastructure strength even as software names sag, hinting at a broader market rotation...
Stocks hover near record levels while consumer sentiment sinks to multi-decade lows. This piece examines trump’s bull...